|
Credit: www.life-worldwide.org |
Coccidioidomycosis is a pulmonary or hematogenously spread
disseminated disease caused by the fungi Coccidioides immitisand C.
posadasii; it usually occurs as an acute benign asymptomatic or self-limited
respiratory infection. The organism occasionally disseminates to cause focal
lesions in other tissues. Symptoms, if present, are those of lower respiratory
infection or low-grade nonspecific disseminated disease. Diagnosis is suspected
based on clinical and epidemiologic characteristics and confirmed by chest
x-ray, culture, and serologic testing. Treatment, if needed, is usually withfluconazole, itraconazole,
newer triazoles, or amphotericin B.
In North America, the endemic area for coccidioidomycosis
includes
- The southwestern US
- Northern Mexico
The affected areas of the southwestern US include Arizona,
the central valley of California, parts of New Mexico, and Texas west of El
Paso. The area extends into northern Mexico, and foci occur in parts of Central
America and Argentina. About 30 to 60% of people who live in an endemic region
are exposed to the fungus at some point during their life. In the US, about
150,000 infections develop annually; over half of them are subclinical.
Pathophysiology
Infections are acquired by inhaling spore-laden dust. Thus,
certain occupations (eg, farming, construction) and outdoor recreational
activities increase risk. Epidemics can occur when heavy rains, which promote
the growth of mycelia, are followed by drought and winds. Because of travel and
delayed onset of clinical manifestations, infections can become evident outside
endemic areas.
Once inhaled, C. immitis spores convert to large
tissue-invasive spherules. As spherules enlarge and then rupture, each releases
thousands of small endospores, which may form new spherules. Pulmonary disease
is characterized by an acute, subacute, or chronic granulomatous reaction with
varying degrees of fibrosis. Lesions may cavitate or form nodular-like coin
lesions.
Sometimes disease progresses, with widespread lung
involvement, systemic dissemination, or both; focal lesions may form in almost
any tissue, most commonly in skin, subcutaneous tissues, bones (osteomyelitis),
and meninges (meningitis).
Progressive coccidioidomycosis is uncommon in otherwise
healthy people and more likely to occur in the following contexts:
- HIV infection
- Use of immunosuppressants
- Advanced age
- 2nd half of pregnancy or postpartum
- Certain ethnic backgrounds (Filipino, African American,
Native American, Hispanic, and Asian, in decreasing order of relative risk)
Symptoms and Signs
Primary coccidioidomycosis
Most patients are asymptomatic, but nonspecific respiratory
symptoms resembling those of influenza, acute bronchitis, or, less often, acute
pneumonia or pleural effusion sometimes occur. Symptoms, in decreasing order of
frequency, include fever, cough, chest pain, chills, sputum production, sore
throat, and hemoptysis.
Physical signs may be absent or limited to scattered rales
with or without areas of dullness to percussion over lung fields. Some patients
develop hypersensitivity to the localized respiratory infection, manifested by
arthritis, conjunctivitis, erythema nodosum, or erythema multiforme.
Read more >>
Source: https://www.merckmanuals.com/professional/infectious-diseases/fungi/coccidioidomycosis